DataKnowledgeCloudtrainingcoordination

COL P16150-1 GLY 000040 (Collection)

Taxon:

Homo sapiens

Taxonomy (Entity type)

Protein:

LEUK HUMAN

Protein (Entity type)

Project:

Portal

Project (Entity type)

Dcc Asset:

glygen 2026 06 06 C2M2.zip

Processed File (Entity type)

Dcc:

GlyGen

DCC (Entity type)

Collection:

human proteoform glycosylation sites unicarbkb.csv

File (Entity type)

Description:Information for protein P16150-1 in the context of file GLY_000040

Creation Time:2026-03-02 19:56:34.000000

Results found

Linked to

	Label	Description
	G43417UB Compound (Entity type)	type="BaseComposition" mass="383.142760805" permass="495.267961365" monosaccharides="2" is_motif="Fa...
	NeuAc(a2-3)Gal(b1-3)[Gal(b1-4)GlcNAc(b1-6)]a-GalNAc Compound (Entity type)	A Compound
	LEUK HUMAN Protein (Entity type)	Leukosialin
	p16150-1 48ser 48ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	p16150-1 103ser 103ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	p16150-1 36thr 36thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	p16150-1 173thr 173thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	p16150-1 28thr 28thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	p16150-1 22thr 22thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	p16150-1 113thr 113thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification

Compound

G43417UB

Compound (Entity type)

type="BaseComposition" mass="383.142760805" permass="495.267961365" monosaccharides="2" is_motif="Fa...

Compound

NeuAc(a2-3)Gal(b1-3)[Gal(b1-4)GlcNAc(b1-6)]a-GalNAc

Compound (Entity type)

A Compound

Protein

LEUK HUMAN

Protein (Entity type)

Leukosialin

Post Translational Modification

p16150-1 48ser 48ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

p16150-1 103ser 103ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

p16150-1 36thr 36thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

p16150-1 173thr 173thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

p16150-1 28thr 28thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

p16150-1 22thr 22thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

p16150-1 113thr 113thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.